Efficacy and safety of neoadjuvant chemotherapy and immunotherapy in locally resectable advanced esophageal squamous cell carcinoma

BACKGROUND: Esophageal squamous cell cancer (ESCC) patients with the potentially resectable disease most would experience relapse after surgery. Immunotherapy has been reported to improve the prognosis of advanced esophageal cancer and may be a new strategy to prevent this urgent condition’s recurre...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Thorac Dis
Main Authors: Wu, Zhigang, Zheng, Qiang, Chen, Haiquan, Xiang, Jiaqing, Hu, Hong, Li, Hang, Pan, Yunjian, Peng, Yizhou, Yao, Xingxin, Liu, Pengcheng, Sun, Yihua, Li, Bin, Zhang, Yawei
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8264718/
https://ncbi.nlm.nih.gov/pubmed/34277047
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd-21-340
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki